How to Critically Appraise the Quality and Risk of Bias in Systematic Reviews of Cost and Cost-Effectiveness Outcomes
Author(s)
Speakers: JL (Hans) Severens, PhD, Bristol-Myers Squibb Foundation, Rotterdam, Netherlands Lena Mandrik, PhD, University of Sheffield, Sheffield, UK; Candyce Hamel, MPH, Canadian Association of Radiologists, Ottawa, ON, Canada
Overview: Speakers will present the main criteria for critical appraisal of systematic reviews of cost and cost-effectiveness outcomes (SR-CCEOs) and introduce the ISPOR CrIteria for Cost (-Effectiveness) Review Outcomes (CiCERO) Checklist. CiCERO comprises the task force’s recommendations and 13 signaling questions to consider when evaluating the risk of bias in SR-CCEOs, as well as the quality of their conduct and reporting. Purpose: There has been a significant increase in the number of SR-CCEOs. The differences in clinical and health settings, heterogeneity in applied methods, and reporting make it challenging to interpret the findings of SR-CCEOs. An analysis of guidelines on conducting and reporting SR-CCEOs resulted in the identification of multiple disagreements in these recommendations, hence the motivation behind the ISPOR Good Practices Task Force Report. Recommendations are organized in six stages:
- planning and development
- search in SR-CCEOs
- study selection and eligibility
- critical appraisal of the included studies
- data extraction and synthesis
- presentation and reporting.
- summarize cost and cost-effectiveness outcomes
- focus on methods of cost and cost-effectiveness studies
- use AMSTAR-2 as the main tool.
Conference/Value in Health Info
2021-05, ISPOR 2021, Montreal, Canada
Code
F6